Images are from whole-mount immunofluorescence microscopy; DAPI (blue) marks chromatin. Antibodies are color-coded. (A) E-cadherin and P-cadherin expression (magnified views at right), summarized in …
Scale bars, 30 μm. (A) FACS strategy to purify WT 2nd telogen HF stem cells (HFSCs) for ELISA. Live cells were first gated with exclusion markers Sca1 (epidermis), CD45 (immune cells), CD140a …
Scale bars, 30 μm. (A) Whole-mount immunofluorescence of adherens junction proteins P-cadherin (PCAD), p120-catenin (p120), β-catenin (β-CAT) and α-catenin (α-CAT). White boxed regions are presented …
Scale bars = 30 μm unless indicated otherwise. (A) Electron microscopy of Cdh1-cKO and WT bulge. (B) Whole-mount immunofluorescence of desmosomal proteins. DSG3, desmoglein 3; DP1/2, desmoplakin …
Scale bars, 30 μm unless indicated otherwise. (A) (Left) Whole-mount immunofluorescence of HFs from mice pulsed with nucleotide analogue EdU for 24 hr prior to analysis. Proliferation dynamics are …
Scale bars, 30 μm. (A) Progeny of the proliferative Cdh1-null HF stem cells maintain expression of the HF stem cell transcription factors TCF4 and LHX2. (B) Whole-mount immunofluorescence of Cdh1-nul…
(A) Gram staining of sagittal skin sections reveals near absence of bacteria in control HFs but presence of Gram-positive (deep violet; arrows) and Gram-negative (pink; arrowheads) bacteria in Cdh1 …
Scale bars, 30 μm. (A) Immunofluorescence (left) and flow cytometry quantifications (right; details below) of immune cells (CD45+) in Sox9CreER; Cdh1fl/fl cKO and control skins. (B) Sagittal skin …
Scale bars, 30 μm. (A) CD45+ immune cells were still recruited to Cdh1 cKO bulge despite the reduced bacterial load by antibiotics treatment. (B) ECAD loss of function specifically in HF stem cells …
Stem cells or inner bulge niche cells were isolated from Sox9CreER cKO or matched littermate heterozygous control animals, that were either treated with low-dose Tamoxifen (Tamlow, to target only …
(A) FACS strategy to purify inner bulge cells from Sox9CreER-activated HFs based on YFP+; Sca1-;CD34-; b1-; CD200Lo. (B) FACS strategy to purify WT bulge HF stem cells in anagen sub-stages II and/or …
Scale bars, 30 μm unless indicated otherwise. (A) Dexamethasone suppressed infiltration of immune cells to the bulge when administered after ECAD loss of function but prior to the immune response,. …
Scale bars, 30 μm. (A) Fgf18 and Bmp6 transcripts remain high in the Cdh1-null inner bulge niche cells. Krt6a encodes K6, a marker of the inner bulge. ns, non-significant. Left are fold-changes …
(A) Relative expression of NOTCH target genes in various HF stem cell and inner bulge populations. *p < 0.05 (absolute fold-change ≥1.5) relative to control HFSCs. (B) Relative expression of HF …
(A, B) Comparisons of transcriptomes of HF stem cells (HFSCs) from Cdh1 cKO vs.Ctrl bulges ±Dex. Venn Diagram (A) showed 392 overlapping genes that were significantly up-regulated (p < 0.05, …
During telogen, inner bulge niche cells express BMP6 and FGF18, which maintain stem cell quiescence. When the sole cadherin (ECAD) of the inner bulge is removed, the niche cannot make adherens …